Literature DB >> 25917045

Role of IL-6 -174(G/C) promoter polymorphism in the etiology of early-onset preeclampsia.

Sabnavis Sowmya1, Aruna Ramaiah, Pratibha Nallari, Akka Jyothy, Ananthapur Venkateshwari.   

Abstract

OBJECTIVE: To investigate the relationship between IL-6 -174G/C promoter polymorphism and preeclampsia.
METHODS: A total of 140 preeclamptic women and 135 women with normal pregnancy were considered for the present study. A standard amplification refractory mutation system PCR was carried out for genotyping of IL-6 G-174C promoter polymorphism. Genotypic distribution was compared with values predicted by Hardy-Weinberg equilibrium using χ (2) test. Odds ratios and their respective 95 % confidence intervals were used to measure the strength of association.
RESULTS: The frequencies observed, CC, GC and GG, were 53.5, 26.6 and 20 % in patients and 26.6, 23.7 and 49.6 % in the controls. There is a significant difference in the distribution of genotypes and alleles of IL-6 G-174 C between the two groups.
CONCLUSION: The present study suggests that the IL-6 -174 promoter polymorphism is a major genetic regulator in the etiology of early-onset preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25917045     DOI: 10.1007/s00011-015-0823-z

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  65 in total

1.  ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms.

Authors:  C Perrey; S J Turner; V Pravica; W M Howell; I V Hutchinson
Journal:  Transpl Immunol       Date:  1999-06       Impact factor: 1.708

2.  Levels of dimethylarginines and cytokines in mild and severe preeclampsia.

Authors:  J Ellis; U B Wennerholm; A Bengtsson; H Lilja; A Pettersson; B Sultan; M Wennergren; H Hagberg
Journal:  Acta Obstet Gynecol Scand       Date:  2001-07       Impact factor: 3.636

3.  Maternal serum levels of interleukin-6 and clinical characteristics of normal delivery at term.

Authors:  K J Arntzen; E Lien; R Austgulen
Journal:  Acta Obstet Gynecol Scand       Date:  1997-01       Impact factor: 3.636

4.  Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation.

Authors:  C F Terry; V Loukaci; F R Green
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

5.  Characterization of the inflammatory cytokines in the vagina during pregnancy and labor and with bacterial vaginosis.

Authors:  H M Imseis; P C Greig; C H Livengood; E Shunior; P Durda; M Erikson
Journal:  J Soc Gynecol Investig       Date:  1997 Mar-Apr

6.  Analysis of polymorphisms in interleukin-10, interleukin-6, and interleukin-1 receptor antagonist in Mexican-Mestizo women with pre-eclampsia.

Authors:  Elith Yazmin Valencia Villalvazo; Thelma Canto-Cetina; Juan Fernando Romero Arauz; Ramón Mauricio Coral-Vázquez; Samuel Canizales-Quinteros; Agustín Coronel; Juan Carlos Falcón; Jaime Hernández Rivera; Roberto Ibarra; Lucila Polanco Reyes; Patricia Canto
Journal:  Genet Test Mol Biomarkers       Date:  2012-09-26

7.  Differential levels of interleukin 6 in maternal and cord sera and placenta in women with pre-eclampsia.

Authors:  S Al-Othman; A E Omu; F M Diejomaoh; M Al-Yatama; F Al-Qattan
Journal:  Gynecol Obstet Invest       Date:  2001       Impact factor: 2.031

8.  Interleukin-6, interferon-gamma, interleukin-8, and granulocyte-macrophage colony stimulating factor levels in human amniotic fluid at term.

Authors:  K S Oláh; G S Vince; J P Neilson; G Deniz; P M Johnson
Journal:  J Reprod Immunol       Date:  1996-11       Impact factor: 4.054

9.  Inhibitory effects of interleukin 6 on prostaglandin I2 production in cultured bovine vascular endothelial cells.

Authors:  N Maruo; I Morita; Y Ishizaki; S Murota
Journal:  Arch Biochem Biophys       Date:  1992-02-01       Impact factor: 4.013

10.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

View more
  2 in total

1.  Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study.

Authors:  Ali S Khashan; Marie Evans; Marius Kublickas; Fergus P McCarthy; Louise C Kenny; Peter Stenvinkel; Tony Fitzgerald; Karolina Kublickiene
Journal:  PLoS Med       Date:  2019-07-30       Impact factor: 11.069

2.  Genetic markers for preeclampsia in Peruvian women.

Authors:  José Pacheco-Romero; Oscar Acosta; Doris Huerta; Santiago Cabrera; Marlene Vargas; Pedro Mascaro; Moisés Huamán; José Sandoval; Rudy López; Julio Mateus; Enrique Gil; Enrique Guevara; Nitza Butrica; Diana Catari; David Bellido; Gina Custodio; Andrea Naranjo
Journal:  Colomb Med (Cali)       Date:  2021-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.